EHS
EHS

In brief

Osteoporosis drug may have CV benefits

The osteoporosis drug alendronate was linked with a reduced risk of cardiovascular (CV) death, heart attack, and stroke according to a study in patients with hip fractures. The association was seen for up to 10 years.

EHS
Back to top button